Updated Pediatric Vaccine Guidelines Represent Significant Paradigm Shifts

This series discusses ongoing changes to the pediatric vaccine schedule and how this is impacting US public health, especially in children.

Over the past several months, the US Department of Health and Human Services (HHS) and the Advisory Committee on Immunization Practices (ACIP) have implemented significant changes to the country’s vaccine guidance framework. Under HHS leadership, including recent appointments to reconstitute ACIP’s membership, federal immunization policy has shifted toward individual-based or shared clinical decision-making for several vaccines. For instance, ACIP voted to end universal hepatitis B vaccination for infants, and HHS wants to scale back the number of recommended vaccinations for children, among other updates in guidelines.

These updates reflect a broader move by HHS to emphasize shared decision-making in vaccine use. Amid these changes, the expertise of pharmacists and health care professionals remains more vital than ever, especially as significant gaps remain in patients’ and caregivers’ understanding of the guidelines and what “shared decision-making” on vaccinations means.

The new federal vaccine guidance has sparked national debate and legal challenges, as states and professional organizations react to these policy shifts. The changes by HHS have reduced the number of vaccines universally recommended for all children, drawing criticism from some public health experts who worry it may lead to lower inoculation rates amid outbreaks of preventable diseases. Several state attorneys general and medical groups have filed lawsuits contesting aspects of the revised childhood vaccine schedule, and many states are independently maintaining their own immunization recommendations or following those of entities such as the American Academy of Pediatrics.

This series features insights from a panel of health care professionals:

• Jacinda Abdul-Mutakabbir, PharmD, MPH, assistant professor of clinical pharmacy and antimicrobial resistance researcher at the University of California San Diego
• Sharon Nachman, MD, chief of the Division of Pediatric Infectious Disease, Stony Brook Children's Hospital, New York
• Mary Koslap-Petraco, DNP, PNP-BC, CPNP, clinical assistant professor at Stony Brook University School of Nursing in Stony Brook
• William Schaffner, MD, professor of medicine in the Division of Infectious Diseases at Vanderbilt University School of Medicine, Nashville, Tennessee

In this episode, the experts discuss updates to pediatric vaccination guidelines, the significant paradigm shifts they represent, and concerns about shifting responsibilities onto individual families and caregivers.

The full series can be viewed here.